Three Decades of Progress in Surgery for Primary Liver Cancer

xinda zhou,zhaoyou tang,yeqin yu
DOI: https://doi.org/10.1007/978-4-431-68541-8_54
1997-01-01
Abstract:This chapter reports the progress of surgery in the treatment of 2388 patients with pathologically proven primary liver cancer (PLC) during the past three decades. The 5- and 10-year survival rates after resection of PLC were 39.3% and 29.2%, respectively, for the whole series (n = 1650), and 61.9% and 45.4%, respectively, for patients with small PLC (≤ 5cm). The 5-year survival rate after cryosurgery was 37.9% for the whole series (n = 191) and 53.1% for patients with small PLC (n = 56). The 5-year survival of 71 patients receiving sequential resection after cytoreduction therapy was 66.0%, and the 5-year survival after reresection for recurrence of tumor (n = 147) was 34.5%. Of 214 patients who survived more than 5 years, 113 patients (52.8%) had a small PLC, and 57 patients survived more than 10 years. Encouraging changes in the prognostic pattern were observed when the PLC data of 1958–1970 (n = 178), 1971–1982 (n = 582), and 1983–1994 (n = 1628) were compared, the 5-year survival rates being 4.8%, 11.2%, and 45.7%, respectively, and the 10-year survival rates being 4.2%, 7.5%, and 33.0%, respectively. Some aspects to prolong survival further are discussed.
What problem does this paper attempt to address?